Bayer AG’s pharmaceuticals unit is on track for a return to growth as new drugs for cancer and kidney disease offset sales ...
To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min In an interview Friday during ...
FRANKFURT (Reuters) -Bayer has told U.S. lawmakers it could stop selling Roundup weedkiller unless they can strengthen legal protection against product liability litigation, according to a financial ...
Bayer CEO Bill Anderson takes the stage at the 2025 CNBC CEO Council Summit to talk to leaders about managing through uncertainty and tackling problems head-on. Got a confidential news tip? We want to ...
The future of Roundup, the world’s most widely used herbicide, hangs in the balance as chemical maker Bayer (OTCPK:BAYZF) (OTCPK:BAYRY) signals it may soon halt production unless it receives legal ...
FRANKFURT, March 7 (Reuters) - Bayer (BAYGn.DE), opens new tab told several brokerages about plans to seek shareholder permission to issue shares one day before formally announcing the news on Friday, ...
At Bayer, a groupwide restructuring is being rolled out as a top priority. But, to Juergen Eckhardt, M.D., who leads both the investment arm Leaps by Bayer and the pharma business development team, ...
Glyphosate-based Roundup is widely used in US farming Bayer paid about $10 bln to settle, billions more at risk German group has lobbied US lawmakers for legal relief Source: Bayer could reach a point ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results